POWERPICC SOLO CATHETER W/ SHERLOCK 3CG (TPS) STYLET 4F FULL TRAY
Report
- Report Number
- 3006260740-2024-04953
- Event Type
- Malfunction
- Date Received
- September 5, 2024
- Date of Event
- August 14, 2024
- Report Date
- November 15, 2024
- Manufacturer
- C.R. BARD, INC. (BASD) -3006260740
- Product Code
- LJS
- PMA / PMN Number
- K091324
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
H11: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD. THE DEVICE HAS NOT BEEN RETURNED TO THE MANUFACTURER FOR EVALUATION.
H11: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD.
IT WAS REPORTED PICC LINE FLUSHED WITH NACL. LEAKING NOTICED FROM EXIT SITE. INCIDENT OCCURRED DURING USE. PATIENT ATTENDED FACILITY FOR REPEAT FBP PRIOR TO SEEING DR, PICC LINE INSITU. PRIOR TO TAKING BLOOD PATIENT STATED THAT THE DISTRICT NURSES HAD EXPERIENCED ISSUES TAKING BLOOD AND WHILE FLUSHING THE PICC LINE THE DN'S AND PATIENT NOTICED OOZING/LEAKING FROM EXIT SITE, COVERED BY BIOPATCH. FBP TAKEN NO ISSUES, GOOD VENOUS RETURN. PICC DRESSING REMOVED, BIOPATCHED REMOVED, PICC LINE FLUSHED WITH NACL. LEAKING NOTICED FROM EXIT SITE. PATIENT DID NOT COMPLAIN OF ANY PAIN OR DISCOMFORT. BUT PATIENT DID STATE HE HAD EXPERIENCED PAIN WHEN THE DN'S WERE FLUSHING IT. THERE WAS A DELAY IN THE PATIENT'S TREATMENT. PICC REMOVED, PATIENT IS AWAITING NEW PICC PLACEMENT. SECURED WITH SECUREACATH. EXIT SITE MARKING 4CM. DRUG DETAILS: FLOT REGIMEN NO OTHER INFORMATION WAS PROVIDED.
IT WAS REPORTED PICC LINE FLUSHED WITH NACL. LEAKING NOTICED FROM EXIT SITE. INCIDENT OCCURRED DURING USE. PATIENT ATTENDED FACILITY FOR REPEAT FBP PRIOR TO SEEING DR, PICC LINE INSITU. PRIOR TO TAKING BLOOD PATIENT STATED THAT THE DISTRICT NURSES HAD EXPERIENCED ISSUES TAKING BLOOD AND WHILE FLUSHING THE PICC LINE THE DN'S AND PATIENT NOTICED OOZING/LEAKING FROM EXIT SITE, COVERED BY BIOPATCH. FBP TAKEN NO ISSUES, GOOD VENOUS RETURN. PICC DRESSING REMOVED, BIOPATCHED REMOVED, PICC LINE FLUSHED WITH NACL. LEAKING NOTICED FROM EXIT SITE. PATIENT DID NOT COMPLAIN OF ANY PAIN OR DISCOMFORT. BUT PATIENT DID STATE HE HAD EXPERIENCED PAIN WHEN THE DN'S WERE FLUSHING IT. THERE WAS A DELAY IN THE PATIENT'S TREATMENT. PICC REMOVED, PATIENT IS AWAITING NEW PICC PLACEMENT. SECURED WITH SECUREACATH. EXIT SITE MARKING 4CM. DRUG DETAILS: FLOT REGIMEN NO OTHER INFORMATION WAS PROVIDED. ADDITIONAL INFORMATION WAS RECEIVED AND ADDED TO FILE ON NOVEMBER 11, 2024 FOR THIS EVENT AS PART OF A FOCUS SURVEY. THE FOLLOWING ADDITIONAL DETAIL WAS PROVIDED: PLACED (B)(6) 2024 REMOVED (B)(6) 2024. TOTAL CATHETER LENGTH 48CM, PLACED IN BASILIC VEIN, EXIT SITE MARKING 3CM, SECURED WITH SECURACATH BETWEEN 1 AND 3CM. PICC USED FOR ONCOLOGY TREATMENT (OXALIPLATIN). NO OCCLUSIONS WITH THIS PICC. LEAKAGE FOUND AT 4CM INTERNALLY. PICC WAS USED 57 DAYS. NO XRAY IMAGING OF THE INCIDENT. CATHETER SITE CLEANED WITH CHLORAPREP (3ML 2% CHG IN 70% IPA). ADDITIONAL COMMENTS: TWO DAYS BEFORE IDENTIFIED THERE WERE ISSUES TAKING BLOODS IN THE COMMUNITY AND PATIENT REMEMBERS PICC LEAKING AT EXIT SITE. NOT OBVIOUS BECAUSE OF BIOPATCH IN PLACE, SEEN IN CLINIC AND DECIDED TO REMOVE AND FRACTURE SEEN. ONCO VAT ONLY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1865509 | POWERPICC SOLO CATHETER W/ SHERLOCK 3CG (TPS) STYLET 4F FULL TRAY | CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS | LJS | C.R. BARD, INC. (BASD) -3006260740 | N/A | REHZ0408 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Other |